ZA964508B - Tricyclic inhibitors of matrix metalloproteinases - Google Patents

Tricyclic inhibitors of matrix metalloproteinases

Info

Publication number
ZA964508B
ZA964508B ZA964508A ZA964508A ZA964508B ZA 964508 B ZA964508 B ZA 964508B ZA 964508 A ZA964508 A ZA 964508A ZA 964508 A ZA964508 A ZA 964508A ZA 964508 B ZA964508 B ZA 964508B
Authority
ZA
South Africa
Prior art keywords
matrix metalloproteinases
gelatinase
inhibitors
tricyclic inhibitors
tricyclic
Prior art date
Application number
ZA964508A
Other languages
English (en)
Inventor
Donald Hupe
Joseph Armand Picard
Qi-Zhuang Ye
Linda Lea Johnson
Andrew David White
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/460,436 external-priority patent/US5665764A/en
Priority claimed from US08/460,437 external-priority patent/US5627206A/en
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of ZA964508B publication Critical patent/ZA964508B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA964508A 1995-06-02 1996-05-31 Tricyclic inhibitors of matrix metalloproteinases ZA964508B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/460,436 US5665764A (en) 1995-06-02 1995-06-02 Tricyclic inhibitors of matrix metalloproteinases
US08/460,437 US5627206A (en) 1995-06-02 1995-06-02 Tricyclic inhibitor of matrix metalloproteinases

Publications (1)

Publication Number Publication Date
ZA964508B true ZA964508B (en) 1996-12-09

Family

ID=27039692

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA964508A ZA964508B (en) 1995-06-02 1996-05-31 Tricyclic inhibitors of matrix metalloproteinases

Country Status (13)

Country Link
EP (1) EP0828726B1 (ko)
JP (1) JPH11506097A (ko)
KR (1) KR19990022171A (ko)
AT (1) ATE206416T1 (ko)
AU (1) AU717570B2 (ko)
CA (1) CA2220040A1 (ko)
DE (1) DE69615680T2 (ko)
DK (1) DK0828726T3 (ko)
ES (1) ES2165496T3 (ko)
MX (1) MX9708728A (ko)
PT (1) PT828726E (ko)
WO (1) WO1996038434A1 (ko)
ZA (1) ZA964508B (ko)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ333064A (en) 1996-09-04 2000-11-24 Warner Lambert Co Subsituted dibenzofurans as inhibitors of matrix metalloproteinases
JP2000517341A (ja) * 1996-09-04 2000-12-26 ワーナー―ランバート・コンパニー マトリックスメタロプロテイナーゼ阻害剤およびそれらの治療的使用
US6624177B1 (en) 1996-09-04 2003-09-23 Warner-Lambert Company Matrix metalloproteinase inhibitors and their therapeutic uses
BR9714385A (pt) * 1996-12-09 2000-05-16 Warner Lambert Co Método para tratamento e prevenção de deficiência cardìaca e dilatação ventricular
EP1366765A1 (en) * 1996-12-17 2003-12-03 Warner-Lambert Company Llc Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing
EP0946166B1 (en) * 1996-12-17 2004-02-18 Warner-Lambert Company LLC Use of matrix metalloproteinase inhibitors for promoting wound healing
US6399612B1 (en) 1997-10-06 2002-06-04 Warner-Lambert Company Heteroaryl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
WO2000006560A1 (en) * 1998-07-30 2000-02-10 Warner-Lambert Company Tricyclic heteroaromatics and their derivatives as inhibitors of matrix metalloproteinases
ES2216614T3 (es) 1998-07-30 2004-10-16 Warner-Lambert Company Llc Sulfonamidas triciclicas y sus derivados como inhibidores de metaloproteinasas de matriz.
DOP2002000334A (es) * 2001-02-14 2002-08-30 Warner Lambert Co Pirimidinas biciclicas como inhibidores de metaloproteinasas de matriz
AU2003253150A1 (en) * 2002-08-13 2004-02-25 Warner-Lambert Company Llc Chromone derivatives as matrix metalloproteinase inhibitors
EA016567B1 (ru) * 2006-08-22 2012-05-30 Ранбакси Лабораториз Лимитед Ингибиторы матриксных металлопротеиназ

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3649651A (en) * 1969-07-02 1972-03-14 American Home Prod Dibenzofuran derivatives and preparation thereof
US5326760A (en) * 1992-06-29 1994-07-05 Glaxo, Inc. Aminobutanoic acid compounds having metalloprotease inhibiting properties

Also Published As

Publication number Publication date
KR19990022171A (ko) 1999-03-25
EP0828726A1 (en) 1998-03-18
DK0828726T3 (da) 2002-01-21
AU717570B2 (en) 2000-03-30
DE69615680D1 (de) 2001-11-08
ATE206416T1 (de) 2001-10-15
JPH11506097A (ja) 1999-06-02
AU5577796A (en) 1996-12-18
DE69615680T2 (de) 2002-07-11
CA2220040A1 (en) 1996-12-05
PT828726E (pt) 2002-03-28
EP0828726B1 (en) 2001-10-04
MX9708728A (es) 1997-12-31
ES2165496T3 (es) 2002-03-16
WO1996038434A1 (en) 1996-12-05

Similar Documents

Publication Publication Date Title
IL123901A (en) Sulfonamide inhibitors of matrix metalloproteinases and pharmaceutical compositions comprising them
ZA964508B (en) Tricyclic inhibitors of matrix metalloproteinases
NZ509439A (en) Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
ZA9610722B (en) Aromatic keto-acids and their derivatives as inhibitors of matrix metalloproteinases
FI953139A (fi) Atovakonia käsittäviä farmaseuttisia koostumuksia
NO972980L (no) Anvendelse av nebivolol som et anti-aterogent middel
NO944448D0 (no) Nye farmasöytiske anvendelser av krill-enzymer
WO2001012592A3 (en) Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
CA2233560A1 (en) Sulfonamide inhibitors of matrix metalloproteinases
AP9701142A0 (en) 4,4-(Disubstituted) cyclohexan-1-ols monomers and related compounds.